Quality of treatment with targeted agents for advanced prostate cancer by treating specialist. Trends in local therapy utilization and survival of patients with de-novo metastatic prostate cancer ...
Real-world data of TAS-102 therapy in refractory metastatic colorectal cancer (mCRC): The experience of the University Hospital of Montreal (CHUM). This is an ASCO Meeting Abstract from the 2024 ASCO ...
To our knowledge, this analysis is the largest EHR-based study for identifying drug repurposing candidates for ALS. We identified several drugs that warrant further assessment as therapeutic options ...
Assessing the risk of radiation-induced hematologic cancer from medical imaging in children and adolescents might support informed decisions on the use of imaging. We followed a retrospective cohort ...
Introduction The PRECISE study demonstrated that the Prospective multicentre imaging study for evaluation of chest pain (PROMISE) Minimal risk score (PMRS) can identify patients with recent onset ...